主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SVRA
#1932
Savara Inc.
6.0
2
+3.44%
版块:
基础:
利润货币:
日范围
年范围
日变化
+3.44%
每月变动
+4.33%
6个月变化
+81.87%
年变化
+147.74%
前一天收盘价
5.8
2
Open
6.0
2
Bid
Ask
Low
6.0
2
High
6.0
2
交易量
89
市场
股票
医疗保健
SVRA
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
54.24 M
114.04 M
114.06 M
138.15 M
172.63 M
—
Valuation ratios
Enterprise value
39.47 M
107.41 M
130.4 M
577.11 M
514.88 M
2.06 B
Price to earnings ratio
—
—
-6.4
-13.24
-6.4
-23.13
Price to sales ratio
—
—
12.86 K
9 499.27
11.93 K
14.68 K
Price to cash flow ratio
—
—
7.06
14.13
6.83
24.89
Price to book ratio
—
—
2.27
5.14
3.55
6.56
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.51
0.24
0.27
0.31
0.45
0.67
Return on equity %
52.67
8 602.8
63.06
201.84
127.84
412.34
Return on invested capital %
732.69
556.73
723.93
1 216.35
3 691.65
—
Gross margin %
100
100
100
100
100
400
Operating margin %
19.18 K
41.9 K
204.42 K
78.96 K
202.35 K
24.95 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
19.31 K
43.45 K
200.79 K
71.97 K
188 K
25.15 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.41
11.26
21.98
15.66
13.73
47.37
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.26
0.1
0.19
0.15
0.13
0.67
Long term debt to total equity ratio
0.39
0.12
0.24
0.19
0.16
0.92
Per share metrics
Operating cash flow per share
—
—
0.23
0.31
0.45
0.47
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
0.82
0.98
0.99
3.04
Net current asset value per share
—
—
0.84
1
1.02
3.13
Tangible book value per share
—
—
0.71
0.85
0.87
2.54
Working capital per share
—
—
0.81
0.94
0.95
2.86
Book value per share
—
—
0.71
0.85
0.87
2.54
新闻
Hercules Capital董事Badavas买入7.5万美元股票
Hercules Capital董事Fallon买入价值14.98万美元股票
Hercules Capital director Fallon buys $149,800 in shares
Citizens重申Savara股票评级,预计FDA批准可能性高
Citizens reiterates Savara stock rating on likely FDA approval
FDA接受Savara罕见肺病药物申请
FDA accepts Savara’s drug application for rare lung disease
Piper Sandler因人工智能颠覆风险下调Hercules Capital股票评级
赫尔克利斯资本公布2025年第四季度初步财务业绩及净资产价值增长
Hercules Capital reports preliminary Q4 2025 financial results and NAV increase
Savara获得额外7500万美元债务融资用于潜在药物上市
Savara修订贷款协议,可获得高达1.05亿美元定期贷款